Fig. 1: LINC01939 is significantly down-regulated and associated with adverse survival of GC patients. | Cell Death & Disease

Fig. 1: LINC01939 is significantly down-regulated and associated with adverse survival of GC patients.

From: LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression

Fig. 1

a Relative expression of LINC01939 in 160 paired gastric cancer (GC) tissues and matched normal tissues by RT-PCR. Results were presented as Δcycle threshold (ΔCt) in tumor tissues relative to normal tissues. b Relative expression of LINC01939 in different clinical stages. LINC01939 expression was lower in patients with advanced-stage GC than those with early-stage GC (**P < 0.01; ***P < 0.005, NS, no significant). The horizontal lines and vertical error bars show mean ± SD (c) and (d) Relative expression of LINC01939 in GC patients with/without lymph node metastasis or with/without distant metastasis. e and f Kaplan-Meier plots of overall-survival (OS) and progression-free survival (PFS) in GC patients with high (n = 79) and low (n = 81) levels of LINC01939. The OS and PFS was significantly shorter in patients with LINC01939 high expression than those with low expression (all P < 0.0001)

Back to article page